K. Kubo

A phase III trial of oral high‐dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer

O. Abe, Y. Nomura, M. Yoshida, 1985, Cancer.

[Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].

O. Abe, H. Koyama, Y. Nomura, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer].

O. Abe, Y. Nomura, M. Yoshida, 1985, Gan no rinsho. Japan journal of cancer clinics.

[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].

O. Abe, Y. Nomura, M. Izuo, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].

K. Inoue, O. Abe, H. Koyama, 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[Clinical evaluation of adriamycin for advanced breast cancer (3)--a joint study by 26 institutes on the CAF and CMcF treatment].

O. Abe, H. Koyama, Y. Nomura, 1983, Gan to kagaku ryoho. Cancer & chemotherapy.

[Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].

O. Abe, M. Yoshida, M. Izuo, 1986, Gan to kagaku ryoho. Cancer & chemotherapy.